2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2010
July 19, 2010
Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
July 19, 2010
Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma - Chinese Version
January 26, 2010
Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
About Aegera
|
Pipeline
|
Clinical Trials
|
Partnerships
|
Media
|
Careers
|
Contact Us
|
Français
© 2010 Aegera Therapeutics Inc. All rights reserved. Developed by
Grafika Designs
.
